Search Results for: right to try

Epithelioid Mesothelioma and Lung Cancer: Biomarker Shows Which is Which
| | |

Epithelioid Mesothelioma and Lung Cancer: Biomarker Shows Which is Which

ByAlex Strauss

Researchers from Hiroshima University say they have found a nearly foolproof way to tell the difference between epithelioid mesothelioma and lung cancer.  This is critical because the prognosis can be very different between the two. They are also treated differently.  But epithelioid mesothelioma and lung cancer are similar in many ways. They cause many of the same symptoms. Even their cells look similar under the microscope. This can make it hard for doctors to deliver an accurate and timely diagnosis.  If the new findings are right, the biomarker identified by the Hiroshima researchers could be a diagnostic gamechanger.  Lung Adenocarcinoma or Pleural Mesothelioma? At first glance, epithelioid mesothelioma and lung cancer seem to be very different. Mesothelioma makes up about…

Free “Surviving Mesothelioma” Book

ByMatt Clarke

“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years…” I was diagnosed in July 1997, and the doctors had given me just a few short months to live. Over 20 years later, I am still sharing my survival secrets in my book “Surviving Mesothelioma.” “Surviving Mesothelioma” is the only book in the world written by me, a 20+ year mesothelioma survivor, and this is the only website where it is available for free. Today, I would like to give you a copy for free. Simply enter your shipping information below now. We will express ship a copy to your door within 72 hours because I want you to survive mesothelioma like I did. *Note: We have limited…

Mesothelioma and Lung Cancer: These Biomarkers Can Tell the Difference
| |

Mesothelioma and Lung Cancer: These Biomarkers Can Tell the Difference

ByAlex Strauss

Researchers in Canada say when it comes to distinguishing between mesothelioma and lung cancer, some proteins are more valuable than others.  The team has identified an especially important protein biomarker for mesothelioma. A biomarker is a compound in body fluid or tissue that can act as a signpost for disease.  Understanding the value of this particular protein as compared to other biomarkers may improve the testing process for mesothelioma. Pleural mesothelioma and lung cancer share many of the same characteristics. Both affect the lungs and both cause similar symptoms. But they are treated differently.  It is not always easy to tell these two cancers apart, even with high-level diagnostic tools. But the biomarker testing completed in Canada may make it…

Immunotherapy for Pleural Mesothelioma: Biomarkers Urgently Needed
| | | | |

Immunotherapy for Pleural Mesothelioma: Biomarkers Urgently Needed

ByAlex Strauss

A new report says biomarkers are urgently needed to determine which patients would benefit from immunotherapy for pleural mesothelioma.  Researchers made the statement in a review of immunotherapy drugs in testing for malignant mesothelioma.  They say some of these drugs have proven to be more effective than others for asbestos cancer. But a set of biomarkers would go a long way to funneling patients into the right immunotherapy for pleural mesothelioma.  The Status of Immunotherapy for Pleural Mesothelioma Immunotherapy is believed to be the most promising up-and-coming cancer treatment. Immunotherapy treatments harness the strength of the body’s own immune response to attack cancer or help other drugs do so.  Like other types of cancer, mesothelioma cells have ways of avoiding…

Curcumin Supplement Delays Mesothelioma Tumor Growth in Mice
| | | | |

Curcumin Supplement Delays Mesothelioma Tumor Growth in Mice

ByAlex Strauss

Italian researchers say a curcumin supplement containing a compound found in black pepper slowed the growth of mesothelioma tumors in mice. The commercially available supplement is called Curcumin-C3complex/Bioperine. This is the first time this formulation has been studied for malignant mesothelioma.  Lab-grown human mesothelioma cells stopped growing when scientists treated them with the curcumin supplement. The treatment did the same in live mice.  The researchers suggest that the curcumin supplement may work synergistically with standard treatments.  What is in Curcumin-C3complex/Bioperine? Curcumin is the most bioactive compound in turmeric. Turmeric is the spice that gives curry its bright yellow color.  Several scientific studies suggest that curcumin and other curcuminoid compounds in turmeric have powerful health benefits. These compounds are anti-inflammatory and…

Risk for Mesothelioma Does Not Decline After Asbestos Exposure Stops
| | |

Risk for Mesothelioma Does Not Decline After Asbestos Exposure Stops

ByAlex Strauss

A new report contains some disappointing news for former asbestos workers: The risk for mesothelioma does not go down when asbestos exposure stops. A team of US and Italian researchers reached that conclusion after combing the medical literature for studies on the risk for mesothelioma. Although the risk for several other cancers declines when the person is no longer in contact with the carcinogen, the study shows this does not apply to asbestos cancer. Asbestos Increases Mesothelioma Risk Asbestos is the primary cause of mesothelioma. It is a naturally-occurring mineral that is resistant to corrosion, does not burn, and makes an excellent insulator. Malignant mesothelioma was virtually unheard of until people started mining and using asbestos in industry. Since then,…

New Mesothelioma Clinical Trial Will Test Personalized Immunotherapy
| | | | | |

New Mesothelioma Clinical Trial Will Test Personalized Immunotherapy

ByAlex Strauss

A Dutch company has recruited the first patients into a pivotal mesothelioma clinical trial of autologous dendritic cells. Dendritic cells are immune system cells that work as messengers. They help tell T cells to attack cancers like malignant mesothelioma. The new mesothelioma clinical trial will test using the patient’s own dendritic cells (autologous cells) as a way to keep cancer from coming back after mesothelioma treatment. Expanding Mesothelioma Treatment Options There is only one approved treatment for malignant pleural mesothelioma. This “standard of care” treatment is chemotherapy with Alimta (pemetrexed) and cisplatin. Although most mesothelioma patients receive this treatment, very few live longer than a year after diagnosis. A Netherlands-based company called Amphera is trying to change those odds. Its…

Survival After Mesothelioma Surgery Could Rise with Immunotherapy Spray
| | | | |

Survival After Mesothelioma Surgery Could Rise with Immunotherapy Spray

ByAlex Strauss

A spray-on immune booster may one day improve survival after mesothelioma surgery. UCLA scientists tested the biodegradable spray gel in mice with advanced melanoma. They found that it stopped cancer recurrence after surgery in about half of the lab animals tested. “Around 90 percent of people with cancerous tumors end up dying because of tumor recurrence or metastasis,” says lead investigator Zhen Gu. “Being able to develop something that helps lower this risk for this to occur and has low toxicity is especially gratifying.” Gu is a professor of bioengineering and a member of the UCLA Jonsson Comprehensive Cancer Center where the spray was developed. Survival After Mesothelioma Surgery Survival after mesothelioma surgery or any other kind of cancer operation…

Japanese Discovery Could Lead to New Mesothelioma Blood Test
| | | | |

Japanese Discovery Could Lead to New Mesothelioma Blood Test

ByAlex Strauss

A discovery in Japan could lead to a more effective mesothelioma blood test for mesothelioma diagnosis. Japanese scientists say they have found a better way to detect mesothelioma cells in the blood.  The scientists are experts in occupational health. Malignant mesothelioma is an occupational cancer because people can get it from working near asbestos. Mesothelioma diagnosis is challenging. But a powerful mesothelioma blood test could make it easier to find the asbestos cancer earlier. Treatment often works better when patients start it earlier. Circulating Tumor Cells in the Blood of Mesothelioma Patients No matter what kind of cancer a person has, their tumor releases some cells into the blood. Mesothelioma tumors are no exception. These circulating tumor cells (CTCs) are…

When Chemotherapy Fails: Apatinib May Offer Third-Line Option for Mesothelioma Patients
| | | |

When Chemotherapy Fails: Apatinib May Offer Third-Line Option for Mesothelioma Patients

ByAlex Strauss

An investigational drug being developed in China may offer a third lifeline to mesothelioma patients whose cancer does not respond to other chemotherapy drugs. Apatinib, also called YN968D1, is a tyrosine kinase inhibitor that is thought to help prevent the formation of blood vessels that mesothelioma tumors need to grow and spread. Right now, there is no approved second-line treatment for pleural mesothelioma, let alone a third-line treatment. Chinese researchers at 363 Hospital in Cheng Du — along with mesothelioma patients around the world — are hoping that apatinib will change that. Mesothelioma Case Study The researchers are hanging their hopes on the case of a 58-year old woman who showed up at their hospital complaining that she had had…